QMMM Holdings Ltd: 2.125M Share IPO at $4 Each Announced by Mark Eisenberg 26.06.2024 "QMMM Holdings Ltd launches 2.125M share IPO at $4 per share. Explore the financial risks and trading considerations. Learn more ...
Rectitude Holdings IPO: Opens at $4 Amid Risk Warnings by Mark Eisenberg 21.06.2024 "Rectitude Holdings IPO launches at $4/share; a guide to understanding associated financial risks, market volatility, and margin trading."
Aureus Greenway Holdings Sets $4-$6 IPO Price for 3.75M Shares by Mark Eisenberg 21.06.2024 Aureus Greenway Holdings files for 3.75M share IPO at $4-$6/sh to raise funds for expansion, highlighting risks and investment considerations.
Zilch Secures £100M, Gears Up for IPO Amid Rapid Growth by Mark Eisenberg 19.06.2024 Zilch secures £100m from Deutsche Bank to triple sales and expand while considering an IPO potentially outside the UK amid ...
China Approves Momenta’s Autonomous Driving US IPO by Mark Eisenberg 19.06.2024 "China's regulator approves autonomous driving startup Momenta's US IPO, highlighting its push for advanced self-driving technologies and market impact."
LandBridge Targets $319M in US IPO with NYSE Listing by Mark Eisenberg 17.06.2024 LandBridge aims to raise up to $319M in U.S. IPO to take advantage of a stronger public market, listing 14.5M ...
Crypto Startups Secure $100B as Bitcoin Surges to $74K by John Darbie 17.06.2024 Crypto investment surged to $2.5B in Q1 2024 amid a market rebound, with Bitcoin hitting $74K. Stablecoins are pivotal to ...
Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive News by Terry Bingman 15.06.2024 Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.
Avidity Biosciences Director Sells $3.8M in Stock by Mark Eisenberg 15.06.2024 Arthur A. Levin sells 40K Avidity shares; BofA ups target to $45 as FDA advances myotonic dystrophy treatment. AI-assisted article ...
Tempus AI Raises $410M in IPO, Sees Revenue Surge by Mark Eisenberg 15.06.2024 Tempus AI sold 11M shares at $37 each, launched in 2015, focuses on medical testing, with revenue growth from $320.7M ...